Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients

BMC Infectious Diseases

Volumn 2, Issue , 2002, Pages

  Wanchu, A ^a   Bhatnagar, A ^a   Khullar, Madhu ^a   Sud, A ^a   Bambery, Pradeep ^a   Singh, Surjit ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD4 ANTIGEN; CITRULLINE; ETHAMBUTOL; ISONIAZID; NITRIC OXIDE; NITRITE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT; ENZYME INHIBITOR;

ADULT; ARTICLE; BACTERIAL SUPERINFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; LUNG TUBERCULOSIS; MALE; MILIARY TUBERCULOSIS; OPPORTUNISTIC INFECTION; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; TUBERCULOSIS; BIOSYNTHESIS; BLOOD; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MYCOBACTERIUM; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CITRULLINE; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; ETHAMBUTOL; FEMALE; HIV INFECTIONS; HUMANS; ISONIAZID; MALE; MIDDLE AGED; MYCOBACTERIUM; NITRIC OXIDE; NITRITES; PYRAZINAMIDE; RIFAMPIN; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

EID: 2942564051     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-2-15     Document Type: Article

References (39)

1. Jimenez JL, Gonzalez-Nicholas J, Alvarez S, Fresno M, Munoz-Fernandez MA: Regulation of Human Immunodeficiency Virus Type I replication in Human T Lymphocytes by Nitric Oxide. J Virol 2001, 75:4655-63
2. Kroncke KD, Feheel K, Kolb-Bachofen V: Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 1998, 113:147-56
3. Moncarda S, Palmer RM, Higgs AE: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1992, 43:109-42
4. Wanchu A, Khullar M, Sud K, Sahkuja V, Thennarasu K, Sud A, Bambery P: A Cross-sectional Analysis of Serum and Urine Nitrite and Citrulline Levels in Patients With Systemic Lupus Erythematosus. JCR: Journal of Clinical Rheumatology 2001, 7:10-5
5. Wanchu A, Khullar M, Sud A, Bambery P: Elevated Nitric Oxide Production in Patients with Primary Sjogren's Syndrome. Clinical Rheumatology 2000, 19:360-4
6. Wanchu A, Khullar M, Sud A, Bambery P: Nitric Oxide Production is increased in patients with Inflammatory Myositis. Nitric Oxide: Biology and chemistry 1999, 3:454-8
7. Wanchu A, Khullar M, Sud A, Deodhar SD, Bambery P: Elevated Urinary Nitrite and Citrulline levels in patients with Rheumatoid Arthritis. Inflammopharmacology 1999, 7:155-61
8. Schmidt HHW, Walter U: NO at work. Cell 1994, 78:918-25
9. Zangerle R, Fuchs D, Reibnegger G, et al: Serum nitrite plus nitrate in infection with human immunodeficiency virus type-I Immunobiology 1995, 193:59-70
10. Hermann E, Idziorek T, Kusnierz JP, Mouton Y, Capron A, Bahr GM: Role of nitric oxide in the regulation of lymphocyte apoptosis and HIV-1 replication. Int J Immunopharmacol 1997, 19:387-97
11. Wanchu A, Khullar M, Bhatnagar A, Sud A, Bambery P, Singh S: Pentoxiphylline Reduces Nitric Oxide Production among Patients with HIV Infection. Immunology Letters 2000, 74:121-5
12. Evans TG, Rasmussen K, Wiebke G, Hibbs JB Jr: Nitric oxide synthesis in patients with advanced HIV infection. Clin Exp Immunol 1994, 97:83-6
13. Wang CH, Lin HC, Liu CY, Huang KH, Huang TT, Yu CT, Kuo HP: Upregulation of inducible nitric oxide synthase and cytokine secretion in peripheral blood monocytes from pulmonary tuberculosis patients. Int J Tuberc Lung Dis 2001, 5:283-91
14. Wang CH, Kuo HP: Nitric oxide modulates interleukin-1beta and tumour necrosis factor-alpha synthesis and disease regression by alveolar macrophages in pulmonary tuberculosis. Respirology 2001, 6:79-84
15. Garcia M, del Llano AM, Cruz-Colon E, Saavedra S, Lavergne JA: Characteristics of nitric oxide-induced apoptosis and its target cells in mitogen-stimulated peripheral blood mononuclear cells from HIV+ subjects. Immunol Invest 2001, 30:267-87
16. Mannick JB, Stamler JS, Teng E, Simpson N, Lawrence J, Jordan J, et al: Nitric oxide modulates HIV-1 replication. J Acquir Immune Defic Syndr 1999, 22:1-9
17. Gonzalez-Nicolas J, Resino S, Jimenez JL, Alvarez S, Fresno M, Munoz-Fernandez MA: Tumor necrosis factor-alpha and nitric oxide in vertically HIV-1-infected children: implications for pathogenesis. Eur Cytokine Netw 2001, 12:437-44
18. Zangerle R, Steinhuber S, Sarcletti M, Dierich MP, Wachter H, Fuchs D, et al: Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals. Int Arch Allergy Immunol 1998, 116:228-39
19. Selwyn PA, Hartel D, Lewis VA, et al: A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989, 320:545-50
20. Wanchu A, Arora S, Bhatnagar A, Sud A, Bambery P, Singh S: Decline in Beta-2 microglobulin levels after anti-tubercular therapy among HIV/TB infected individuals. Indian Journal of Chest Diseases and Allied Sciences 2001, 43:211-5
21. Schon T, Gebre N, Sundqvist T, Aderaye G, Britton S: Effects of HIV co-infection and chemotherapy on the urinary levels of nitric oxide metabolites in patients with pulmonary tuberculosis. Scand J Infect Dis 1999, 31:123-6
22. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnock JS, Tannenbaum SR: Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Ann Biochem 1982, 126:131-8
23. Boyde TR, Rahamatullah M: Optimization of conditions for the calorimetric determination of citrulline, using diacetyl monoxime. Ann Biochem 1980, 107:424-31
24. Huang FP, Niedbala W, Wei QX: Nitirc oxide regulates Th1 cell development through the inhibition of IL-2 synthesis by macrophages. Eur J Immunol 1998, 28:4060-70
25. Moilanen E, Vapaatalo H: Nitric oxide in inflammation and immune response. Ann Med 1995, 27:359-67
26. Lander HM, Sehajpal P, Levine DM, Novogrodsky A: Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol 1993, 150:1509-16
27. Williams SM, Noguchi S, Henkart PA, Osawa Y: Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. J Immunol 1998, 161:6526-31
28. Fauci AS: Host factors in the pathogenesis of HIV disease. Antibiot Chemother 1996, 48:4-12
29. Giovannoni G, Miller RF, Heales SJ, Land JM, Harrioson MJ, Thompson EJ: Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: a correlation with bloodbrain - barrier dysfunction. J Neurol Sci 1998, 156:53-8
30. Torre D, Ferrario G, Bonetta G, Speranza F, Zeroli C: Production of nitric oxide from peripheral blood mononuclear cells and polymorphonuclear leukocytes of patients with HIV-1 infection AIDS 1995, 9:979-80
31. Torre D, Ferrario G: Immunological aspects of nitric oxide in HIV-1 infection. Med Hypotheses 1996, 47:405-7
32. Long R, Light B, Talbot JA: Antimicrob agents Chemother 1999, 43:403-5
33. Yu K, Mirchell C, Xing Y, Magiliozzo RS, Bloom RS, Chan J: Tuber Lung Dis 1999, 79:191-8
34. MacMiking JD, North RJ, La Course R: Proc Natl Acad Sci USA 1997, 94:5243-8
35. Bergamini A, Faggioli E, Bolacchi F, et al: Enhanced production of tumor necrosis factor-alpha and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1. J Infect Dis 1999, 179:832-42
36. Mohan VP, Scanga CA, Yu K, et al: Effects of tumour necrosis factor alpha on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology. Infection Immun 2001, 69:1847-55
37. Immanuel C, Rajeswari R, Rahman F, Kumaran PP, Chandrasekaran V, Swamy R: Serial evaluation of serum neopterin in HIV seronegative patients treated for tuberculosis. Int J Tuberc Lung Dis 2001, 5:185-90
38. Nathan C, Shiloh MU: Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci 2000, 97:8841-8
39. Calleja C, Pascussi JM, Mani JC, Maurel P, Vilarem MJ: The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Natr Med 1998, 4:92-6